Latest Breaking News On - சிரஸ் தர்க்கம் - Page 5 : comparemela.com

Were Hedge Funds Right About Beam Therapeutics Inc. (BEAM)? At Insider Monkey, we pore over the filings of nearly 866 top investment firms every quarter, a process we have now completed for the latest reporting period. The data we’ve gathered as a result gives us access to a wealth of collective knowledge based on these firms’ portfolio holdings as of March 31st. In this article, we will use that wealth of knowledge to determine whether or not Beam Therapeutics Inc. (NASDAQ:BEAM) makes for a good investment right now. Beam Therapeutics Inc. (NASDAQ:BEAM) investors should pay attention to an increase in hedge fund interest lately. Beam Therapeutics Inc. (NASDAQ:BEAM) was in 18 hedge funds’ portfolios at the end of the first quarter of 2021. The all time high for this statistic was previously 14. This means the bullish number of hedge fund positions in this stock currently sits at its all time high. Our calculations also showed that BEAM isn’t among the 30 most popular stocks

Jim cramerAlan howard brevanAllogene therapeutics incBeam therapeutics incRedmile groupBearings incorporatedEmergent biosolutions incWebster financial corporationCirrus logic incUnited bankshares incBeam therapeuticsZhang hillhouse capitalLei zhangHillhouse capitalInsider monkeyGood stock to buy